nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—TUBB4B—Vincristine—sarcoma	0.434	0.486	CbGbCtD
Mebendazole—CYP1A1—Dacarbazine—sarcoma	0.148	0.166	CbGbCtD
Mebendazole—CYP3A4—Thiotepa—sarcoma	0.0626	0.0701	CbGbCtD
Mebendazole—ABCB1—Dactinomycin—sarcoma	0.0502	0.0562	CbGbCtD
Mebendazole—ABCB1—Mitoxantrone—sarcoma	0.0449	0.0503	CbGbCtD
Mebendazole—ABCB1—Vincristine—sarcoma	0.0309	0.0346	CbGbCtD
Mebendazole—ABCB1—Etoposide—sarcoma	0.0283	0.0317	CbGbCtD
Mebendazole—CYP3A4—Mitoxantrone—sarcoma	0.0269	0.0301	CbGbCtD
Mebendazole—ABCB1—Doxorubicin—sarcoma	0.0193	0.0216	CbGbCtD
Mebendazole—CYP3A4—Vincristine—sarcoma	0.0185	0.0207	CbGbCtD
Mebendazole—CYP3A4—Etoposide—sarcoma	0.017	0.019	CbGbCtD
Mebendazole—CYP3A4—Doxorubicin—sarcoma	0.0116	0.013	CbGbCtD
Mebendazole—Prolonged menses—Vincristine—sarcoma	0.00676	0.195	CcSEcCtD
Mebendazole—TUBA1A—mammary gland—sarcoma	0.00453	0.0623	CbGeAlD
Mebendazole—TUBA1A—myometrium—sarcoma	0.00321	0.0442	CbGeAlD
Mebendazole—TUBA1A—embryo—sarcoma	0.00309	0.0425	CbGeAlD
Mebendazole—TUBB4B—mammary gland—sarcoma	0.00302	0.0415	CbGeAlD
Mebendazole—TUBA1A—seminal vesicle—sarcoma	0.0029	0.0399	CbGeAlD
Mebendazole—TUBA1A—hematopoietic system—sarcoma	0.00276	0.038	CbGeAlD
Mebendazole—TUBA1A—connective tissue—sarcoma	0.00265	0.0366	CbGeAlD
Mebendazole—TUBA1A—smooth muscle tissue—sarcoma	0.00243	0.0334	CbGeAlD
Mebendazole—TUBA1A—skin of body—sarcoma	0.0024	0.033	CbGeAlD
Mebendazole—TUBB4B—myometrium—sarcoma	0.00214	0.0295	CbGeAlD
Mebendazole—TUBA1A—cardiac atrium—sarcoma	0.00209	0.0288	CbGeAlD
Mebendazole—TUBA1A—uterus—sarcoma	0.00208	0.0287	CbGeAlD
Mebendazole—TUBB4B—embryo—sarcoma	0.00206	0.0283	CbGeAlD
Mebendazole—TUBA1A—lymphoid tissue—sarcoma	0.00194	0.0267	CbGeAlD
Mebendazole—TUBB4B—seminal vesicle—sarcoma	0.00193	0.0266	CbGeAlD
Mebendazole—Menorrhagia—Vincristine—sarcoma	0.00192	0.0551	CcSEcCtD
Mebendazole—Menorrhagia—Mitoxantrone—sarcoma	0.00187	0.0537	CcSEcCtD
Mebendazole—TUBB4B—hematopoietic system—sarcoma	0.00184	0.0253	CbGeAlD
Mebendazole—TUBA1A—tendon—sarcoma	0.00182	0.0251	CbGeAlD
Mebendazole—TUBB4B—connective tissue—sarcoma	0.00177	0.0244	CbGeAlD
Mebendazole—TUBA1A—bone marrow—sarcoma	0.00177	0.0243	CbGeAlD
Mebendazole—TUBB4B—smooth muscle tissue—sarcoma	0.00162	0.0223	CbGeAlD
Mebendazole—TUBB4B—skin of body—sarcoma	0.0016	0.022	CbGeAlD
Mebendazole—TUBA1A—testis—sarcoma	0.00151	0.0208	CbGeAlD
Mebendazole—TUBA1A—liver—sarcoma	0.00143	0.0197	CbGeAlD
Mebendazole—TUBB4B—cardiac atrium—sarcoma	0.0014	0.0192	CbGeAlD
Mebendazole—TUBB4B—uterus—sarcoma	0.00139	0.0191	CbGeAlD
Mebendazole—TUBB4B—lymphoid tissue—sarcoma	0.00129	0.0178	CbGeAlD
Mebendazole—TUBB4B—tendon—sarcoma	0.00122	0.0167	CbGeAlD
Mebendazole—TUBB4B—bone marrow—sarcoma	0.00118	0.0162	CbGeAlD
Mebendazole—TUBA1A—lymph node—sarcoma	0.0011	0.0151	CbGeAlD
Mebendazole—CYP1A1—hematopoietic system—sarcoma	0.00103	0.0142	CbGeAlD
Mebendazole—TUBB4B—testis—sarcoma	0.00101	0.0139	CbGeAlD
Mebendazole—TUBB4B—liver—sarcoma	0.000952	0.0131	CbGeAlD
Mebendazole—Neutropenia—Dactinomycin—sarcoma	0.000931	0.0268	CcSEcCtD
Mebendazole—CYP1A1—skin of body—sarcoma	0.000895	0.0123	CbGeAlD
Mebendazole—Agranulocytosis—Thiotepa—sarcoma	0.000835	0.024	CcSEcCtD
Mebendazole—Neutropenia—Vincristine—sarcoma	0.000832	0.0239	CcSEcCtD
Mebendazole—Agranulocytosis—Dactinomycin—sarcoma	0.000828	0.0238	CcSEcCtD
Mebendazole—Neutropenia—Mitoxantrone—sarcoma	0.00081	0.0233	CcSEcCtD
Mebendazole—Hepatitis—Dactinomycin—sarcoma	0.000797	0.0229	CcSEcCtD
Mebendazole—CYP1A1—cardiac atrium—sarcoma	0.000781	0.0108	CbGeAlD
Mebendazole—CYP1A1—uterus—sarcoma	0.000777	0.0107	CbGeAlD
Mebendazole—CYP3A4—hematopoietic system—sarcoma	0.000755	0.0104	CbGeAlD
Mebendazole—TUBB4B—lymph node—sarcoma	0.00073	0.0101	CbGeAlD
Mebendazole—Agranulocytosis—Mitoxantrone—sarcoma	0.000721	0.0207	CcSEcCtD
Mebendazole—Hepatitis—Mitoxantrone—sarcoma	0.000693	0.0199	CcSEcCtD
Mebendazole—Neutropenia—Etoposide—sarcoma	0.000674	0.0194	CcSEcCtD
Mebendazole—ABCB1—myometrium—sarcoma	0.000622	0.00857	CbGeAlD
Mebendazole—Convulsion—Thiotepa—sarcoma	0.000605	0.0174	CcSEcCtD
Mebendazole—Agranulocytosis—Etoposide—sarcoma	0.000599	0.0172	CcSEcCtD
Mebendazole—ABCB1—embryo—sarcoma	0.000599	0.00824	CbGeAlD
Mebendazole—ABCB1—seminal vesicle—sarcoma	0.000562	0.00774	CbGeAlD
Mebendazole—Convulsion—Vincristine—sarcoma	0.000537	0.0154	CcSEcCtD
Mebendazole—ABCB1—hematopoietic system—sarcoma	0.000534	0.00736	CbGeAlD
Mebendazole—CYP1A1—liver—sarcoma	0.000533	0.00734	CbGeAlD
Mebendazole—Convulsion—Mitoxantrone—sarcoma	0.000523	0.015	CcSEcCtD
Mebendazole—Gastrointestinal pain—Thiotepa—sarcoma	0.000466	0.0134	CcSEcCtD
Mebendazole—Gastrointestinal pain—Dactinomycin—sarcoma	0.000463	0.0133	CcSEcCtD
Mebendazole—Urticaria—Thiotepa—sarcoma	0.000453	0.013	CcSEcCtD
Mebendazole—Abdominal pain—Thiotepa—sarcoma	0.000451	0.013	CcSEcCtD
Mebendazole—Abdominal pain—Dactinomycin—sarcoma	0.000447	0.0129	CcSEcCtD
Mebendazole—Convulsion—Etoposide—sarcoma	0.000435	0.0125	CcSEcCtD
Mebendazole—Hypersensitivity—Thiotepa—sarcoma	0.00042	0.0121	CcSEcCtD
Mebendazole—Hypersensitivity—Dactinomycin—sarcoma	0.000417	0.012	CcSEcCtD
Mebendazole—Gastrointestinal pain—Vincristine—sarcoma	0.000414	0.0119	CcSEcCtD
Mebendazole—CYP1A1—lymph node—sarcoma	0.000409	0.00563	CbGeAlD
Mebendazole—ABCB1—uterus—sarcoma	0.000404	0.00556	CbGeAlD
Mebendazole—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000403	0.0116	CcSEcCtD
Mebendazole—Abdominal pain—Vincristine—sarcoma	0.0004	0.0115	CcSEcCtD
Mebendazole—Urticaria—Mitoxantrone—sarcoma	0.000391	0.0113	CcSEcCtD
Mebendazole—CYP3A4—liver—sarcoma	0.000391	0.00539	CbGeAlD
Mebendazole—Abdominal pain—Mitoxantrone—sarcoma	0.000389	0.0112	CcSEcCtD
Mebendazole—Neutropenia—Epirubicin—sarcoma	0.000378	0.0109	CcSEcCtD
Mebendazole—ABCB1—lymphoid tissue—sarcoma	0.000376	0.00518	CbGeAlD
Mebendazole—Hypersensitivity—Vincristine—sarcoma	0.000373	0.0107	CcSEcCtD
Mebendazole—Hypersensitivity—Mitoxantrone—sarcoma	0.000363	0.0104	CcSEcCtD
Mebendazole—Rash—Thiotepa—sarcoma	0.00036	0.0103	CcSEcCtD
Mebendazole—Dermatitis—Thiotepa—sarcoma	0.000359	0.0103	CcSEcCtD
Mebendazole—Rash—Dactinomycin—sarcoma	0.000357	0.0103	CcSEcCtD
Mebendazole—Neutropenia—Doxorubicin—sarcoma	0.000349	0.0101	CcSEcCtD
Mebendazole—ABCB1—bone marrow—sarcoma	0.000343	0.00472	CbGeAlD
Mebendazole—Agranulocytosis—Epirubicin—sarcoma	0.000336	0.00967	CcSEcCtD
Mebendazole—Gastrointestinal pain—Etoposide—sarcoma	0.000335	0.00964	CcSEcCtD
Mebendazole—Urticaria—Etoposide—sarcoma	0.000325	0.00936	CcSEcCtD
Mebendazole—Abdominal pain—Etoposide—sarcoma	0.000324	0.00932	CcSEcCtD
Mebendazole—Hepatitis—Epirubicin—sarcoma	0.000323	0.0093	CcSEcCtD
Mebendazole—Rash—Vincristine—sarcoma	0.000319	0.00917	CcSEcCtD
Mebendazole—Dermatitis—Vincristine—sarcoma	0.000319	0.00917	CcSEcCtD
Mebendazole—Agranulocytosis—Doxorubicin—sarcoma	0.000311	0.00894	CcSEcCtD
Mebendazole—Rash—Mitoxantrone—sarcoma	0.000311	0.00893	CcSEcCtD
Mebendazole—Dermatitis—Mitoxantrone—sarcoma	0.00031	0.00893	CcSEcCtD
Mebendazole—Hypersensitivity—Etoposide—sarcoma	0.000302	0.00868	CcSEcCtD
Mebendazole—Hepatitis—Doxorubicin—sarcoma	0.000299	0.0086	CcSEcCtD
Mebendazole—ABCB1—testis—sarcoma	0.000293	0.00403	CbGeAlD
Mebendazole—ABCB1—liver—sarcoma	0.000277	0.00381	CbGeAlD
Mebendazole—Rash—Etoposide—sarcoma	0.000258	0.00743	CcSEcCtD
Mebendazole—Dermatitis—Etoposide—sarcoma	0.000258	0.00742	CcSEcCtD
Mebendazole—Convulsion—Epirubicin—sarcoma	0.000244	0.00701	CcSEcCtD
Mebendazole—Convulsion—Doxorubicin—sarcoma	0.000226	0.00649	CcSEcCtD
Mebendazole—ABCB1—lymph node—sarcoma	0.000212	0.00292	CbGeAlD
Mebendazole—Gastrointestinal pain—Epirubicin—sarcoma	0.000188	0.0054	CcSEcCtD
Mebendazole—Urticaria—Epirubicin—sarcoma	0.000182	0.00525	CcSEcCtD
Mebendazole—Abdominal pain—Epirubicin—sarcoma	0.000182	0.00522	CcSEcCtD
Mebendazole—Gastrointestinal pain—Doxorubicin—sarcoma	0.000174	0.005	CcSEcCtD
Mebendazole—Hypersensitivity—Epirubicin—sarcoma	0.000169	0.00487	CcSEcCtD
Mebendazole—Urticaria—Doxorubicin—sarcoma	0.000169	0.00486	CcSEcCtD
Mebendazole—Abdominal pain—Doxorubicin—sarcoma	0.000168	0.00483	CcSEcCtD
Mebendazole—Hypersensitivity—Doxorubicin—sarcoma	0.000157	0.0045	CcSEcCtD
Mebendazole—Rash—Epirubicin—sarcoma	0.000145	0.00417	CcSEcCtD
Mebendazole—Dermatitis—Epirubicin—sarcoma	0.000145	0.00416	CcSEcCtD
Mebendazole—Rash—Doxorubicin—sarcoma	0.000134	0.00385	CcSEcCtD
Mebendazole—Dermatitis—Doxorubicin—sarcoma	0.000134	0.00385	CcSEcCtD
